Effects of PBMC and Combined-PBMC with BM-MSCs to the Expression of α2β1 Integrin Level on Full Thickness Rat’ Burn Skin
AbstractBone marrow mesenchymal stem cells (BM-MSCs) increases the percentage of integrin α2β1 expression on rat’ wound healing process, but the study which is related to PBMC (peripheral blood mononuclear cell) and PBMC combined with BM-MSCs towards burn healing process has not been conducted yet. The aim of the study was to determine the expression of integrin α2β1 as a result of PBMC and PBMC combined to BM-MSCs administrations towards rat’ wound healing process. Experimental research with the post test only control design was conducted on 12 Wistar rats, divided into three experimental groups: PBS (Phosphate Buffer Saline) as control group, PBMC, and PBMC combined with BM-MSCs. Stem cells were subcutaneously injected with 2x106 cells/ml. A full-thickness burn was made on the dorsal side (back). Skin tissues were collected to investigate the expression of integrin α2β1 using immunohistochemistry method on day-14.Administration of only PBMC (2.972), and PBMC combined with BM-BSCs (3.297) elevated the percentage of integrin α2β1 compared with control group (2.340), but significant result was only in combination group (p=0,05). The administration of only PBMC and PBMC combined with BM-MSCs elevated the expression of integrin α2β1, which showed that both of stem cells accelerated the migration of keratinocyts that will expedite the re-epithelialization phase in burn wound healing.
. R. Abe , SC. Donnelly, T Peng, R. Bucala, CN. Metz. 2001. “Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.”. J Immunol. [On- line]. 166, pp.7556-62. Available: www.ncbi.nlm.nih.gov/ pubmed/ 11390511[May. 24, 2016]
. CR. Kleiveland. “Peripheral blood mononuclear cells.” in The impact of food bioactives on health.Verhoeckx K. et al. (eds). Springer, Cham, 2015, pp.161-167
. MF. Pittenger, AM Mackay, SC. Beck, RK. Jaiswal, R. Douglas, JD. Mosca, MA. Moorman, DW. Simonetti, S. Craig, DR. Marshak. 1996. “Multilineage potential of adult human mesenchymal stem cells.” [On- line]. Science. [On- line]. 284,pp.143-7. Available: www.ncbi.nlm.nih.gov/pubmed/10102814 [Apr. 05, 2016]
. G. Roshanak, Z. Dimitra, L. Hongzhe, CL. Hooi, S. Shamit & S. Stefan. 2017. “Human primary bone marrow mesenchymal stromal cells and their in vitro progenies display distinct transcriptional profile signatures.” Scientific Reports, [On- line]. 7(10338). doi:10.1038/s41598-017-09449-x. Available: https://www.nature. com/articles/s41598-017-09449-x [Jan. 12, 2018]
. G. Revilla, E. Darwin, Yanwirasti, FA. Rantam. 2016. “Effect of allogeneic bone marrow-mesenchymal stem cells (bm-mscs) to accelerate burn healing of rat on the expression of collagen type I and integrin α2β1.” Pak J Biol Sci, [On- line]. 19(8-9),pp.345-351. doi: 10.3923/pjbs.2016.345.351. Available: www.ncbi.nlm.nih.gov/ pubmed/29023021 [Apr. 05, 2016]
. G. Revilla, E. Darwin, Yanwirasti, and FA. Rantam. “Effects of peripheral blood mononuclear cells (PBMC) to the expression of type-1 collagen in rat burns,” presented at the 4th Scientific Consortium. Annual meeting of hypoxia and oxidative stress studies, Jakarta, 2014.
. H. Jian, C. Ming, Q. Lijun, W. Junhong, G. Yan, and X. Di. 2017. “Fibrillar type I collagen enhances the differentiation and proliferation of myofibroblasts by lowering α2β1 2017integrin expression in cardiac fibrosis.” Biomed Res Int, [On- line] 1790808. doi: 10.1155/2017/1790808. Available: www.hindawi. com/journals/bmri/2017/1790808/ [Jan. 12, 2018]
. M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, H. Shimizu. 2008. “Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by trans-differentiation into multiple skin cell type.” J Immunol, [On- line] 180,pp.2581-7. PMID: 18250469. Available: www.ncbi.nlm.nih.gov/pubmed/18250469 [Apr. 05, 2016]
. BJ. Herdrich, RC. Lind, KW. Liechty. 2008. “Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds.” Cytotherapy, [On- line] 10,pp.543-50. doi: 10.1080/14653240802345820. Available:/www.ncbi.nlm.nih.gov/pubmed/18836914 [Apr. 05, 2016]
. Medina, RT. Kilani, N. Carr, E. Brown, A. Ghahary. 2007. “Transdifferentiation of peripheral blood mononuclear cells into epithelial-like cells.” Am J Pathol, [On- line] 171,pp1140–1152. doi: 10.2353/ajpath.2007.070051. Available: www.ncbi.nlm.nih.gov/pubmed/17717137 [Apr. 05, 2016]
. EK. Moioli, PA. Clark, M. Chen, JE. Dennis, HP. Erickson, SL. Gerson, et al. 2008. “Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.” PLoS ONE, [On- line] 3:e3922. https://doi.org/10.1371/ journal. pone.0003922. Available: journals.plos.org/plosone/ article?id=10.1371/journal.pone.0003922[Apr. 05, 2016]
. WHO. “Burns.” http://www.who.int/news-room/fact-sheets/detail/burns, March, 6, 2018 [June, 7, 2018].
. AK. Vern, BA. Latenser. “Specimen collection and analysis,” in Burns Wound Healing. DiPietro, Luisa A, L. Aime. (eds). Vol.78. Totowa: Humana Press, 2003,pp.241-254.
. HP. Lorenz, MT. Longaker. “Wounds: biology, pathology, and management,” in Surgery: Norton J.A. et al. (eds), New York: Springer, 2008,pp.77-88.
. K. Kotowicz, GL. Dixon, NJ. Klein, MJ. Peters, RE. Callard. 2000. “Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes.” Immunology, [On- line], 100,pp.441-8. Available: www.ncbi.nlm.nih.gov/pubmed/10929070 [Apr. 05, 2016]
. J. Xupin, T. Miao, G. Xiaowei, Z. Dongxia, Z. Qiong, Z. Jiaping, H. Yuesheng. 2014. “Switch from avb5 to avb6 integrin is required for CD9-regulated keratinocyte migration and MMP-9 activation.: FEBS Letters, [On- line], 588 (2014),pp.4044–4052. http://dx.doi.org/10.1016/j.febslet.2014.09.027. Available: febs.onlinelibrary. wiley.com/doi/pdf/10.1016/j.febslet.2014.09.027 [Apr. 05, 2016]
. F. Decline, P. Rousselle. 2001. “Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain.” J Cell Sci. [On- line], 114,pp.811-23. PMID: 11171386. Available: www.ncbi. nlm.nih.gov/pubmed/11171386 [Apr. 05, 2016]
. VA. Paramonov, VY. Chebotarev. 2002. “Modeling of thermal skin injury for the development of local treatment drugs.” Bull Exp Biol Med, [On- line] 134,pp.512-515. PMID: 12802465. Available: www.ncbi. nlm.nih.gov/pubmed/12802465[Apr. 05, 2016]
. ZG. Zhang, I. Bothe, F. Hirche, M. Zweers et al. 2006. “Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of α2 β1 integrin.” Journal of Cell Science, [On- line] 119,pp.1886-1895. doi: 10.1242/jcs.02921. Available: jcs.biologists.org/content/119/9/1886 [Apr. 05, 2016]
. Z. Jun, H. Xiaowen, W. Haijun, L. Xiaoyan, Z. Tao, W. Yunchuan, and H. Dahai. 2015. “The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy.” Stem Cell Res Ther. [On- line], 15(6),pp.234. doi: 10.1186/s13287-015-0240-9. Available: www.ncbi.nlm.nih.gov/pmc/articles/PMC4665863/ [Apr. 05, 2016]
. JA. Semon, LH. Nagy, CB. Llamas, HA. Tucker, RH. Lee, DJ. Prockop. 2010. “Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels.” Cell Tissue Res, [On- line], 341,pp.147-58. doi: 10.1007/s00441-010-0994-4. Available: www.ncbi.nlm.nih.gov/pubmed/20563599 [Apr. 05, 2016]
. EF. Srour, A. Jetmore, FM. Wolber, PA. Plett, R. Abonour, MC. Yoder, CM. Orschell-Traycoff. 2001. “Homing, cell cycle kinetics and fate of transplanted hematopoietic stem cells.” Leukemia, [On- line], 15,pp.1681-4. PMID: 11681406. Available: www.ncbi.nlm.nih.gov/pubmed/11681406[Apr. 05, 2016]
. FM. Watt. 2002. “Role of integrins in regulating epidermal adhesion, growth and differentiation.” EMBO J. [On- line], 21,pp.3919-26. doi: 10.1093/emboj/cdf399. Available: www.ncbi.nlm.nih.gov/pubmed/12145193 ` [Apr. 05, 2016]
. R. Tamma and D. Ribatti. 2017. “Bone niches, hematopoietic stem cells, and vessel formation.” Int J Mol Sci, [On- line], 18,pp.151. doi: 10.3390/ijms18010151. Available: www.ncbi.nlm.nih.gov/pubmed/28098778 [June, 7, 2018].
. P. Irenaar, S. Olivera, C. Natalie, Yin, R. Horacio, G. Aron, Nusbaum, S. Andrew, B. Shailee, Patel, K. Laiqua, R. Rivkah, Isseroff, and M. Tomic-Canic. 2014. “Epithelialization in wound healing: a comprehensive review.” Adv Wound Care (New Rochelle) [On- line]. 3(7),pp. 445–464. doi: 10.1089/wound.2013.0473. Available: www.ncbi.nlm.nih.gov/pubmed/25032064[Apr. 05, 2016]
. DT. Woodley, A. Wysong, B. DeClerck, M. Chen, and W. Li. 2015. “Keratinocyte migration and a hypothetical new role for extracellular heat shock protein 90 alpha in orchestrating skin wound healing.” Adv Wound Care (New Rochelle), [On- line], 4(4),pp.203–212. doi: 10.1089/wound.2014.0566. Available: www.ncbi.nlm. nih.gov/pmc/articles/PMC4397998/[Apr. 05, 2016]
. LE. Reynolds, FJ. Conti, M. Lucas, R. Grose, S. Robinson, M. Stone, G. Saunders, C. Dickson, RO. Hynes, A. Lacy-Hulbert, K. Hodivala-Dilke. 2005. “Accelerated re-epithelialization in beta3-integrin-deficient-mice is associated with enhanced TGF-beta1 signaling.” Nat Med, [On- line], 11,pp.167-74. doi: 10.1038/nm1165. Available: www.ncbi.nlm.nih.gov/pubmed/15654327[Apr. 05, 2016]
. B. Steffensen, L. Häkkinen, H. Larjava. 2001. “Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.” Crit Rev Oral Biol Med, [On- line], 12,pp.373-98. PMID: 12002821. Available: www.ncbi.nlm.nih.gov/pubmed/12002821[Apr. 05, 2016]
. L. Koivisto, J. Heino, L. Häkkinen, and H. Larjava. 2014. “Integrins in Wound Healing.” Adv Wound Care (New Rochelle), [On- line], 3(12),pp.762–783. doi: 10.1089/wound.2013.0436. Available: www.ncbi.nlm.nih. gov/pubmed/25493210[Apr. 05, 2016]
. G. Revilla, E. Darwin, Yanwirasti and FA. Rantam. 2015. “The therapy of burn healing in Rat (Wistar) by using the combination of peripheral blood mononuclear cells (PBMC) and bone marrow BM-derived mesenchymal stem cell.” African Journal of Internal Medicine, [On- line], 3,pp.162-167. ISSN: 2326-7283. Available: internationalscholarsjournals.org/download.php?id=827856401189940565.pdf&type=application/pdf&op=1[Apr. 05, 2016]
. T. Tsuji. 2004. “Physiological and pathological role of α3β1 integrin.” The Journal of Membrane Biology, [On- line], 200,pp.115-132. Available: link.springer.com/article/10.1007/s00232-004-0696-5[Apr. 05, 2016]
Authors who submit papers with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- By submitting the processing fee, it is understood that the author has agreed to our terms and conditions which may change from time to time without any notice.
- It should be clear for authors that the Editor In Chief is responsible for the final decision about the submitted papers; have the right to accept\reject any paper. The Editor In Chief will choose any option from the following to review the submitted papers:A. send the paper to two reviewers, if the results were negative by one reviewer and positive by the other one; then the editor may send the paper for third reviewer or he take immediately the final decision by accepting\rejecting the paper. The Editor In Chief will ask the selected reviewers to present the results within 7 working days, if they were unable to complete the review within the agreed period then the editor have the right to resend the papers for new reviewers using the same procedure. If the Editor In Chief was not able to find suitable reviewers for certain papers then he have the right to accept\reject the paper.B. sends the paper to a selected editorial board member(s). C. the Editor In Chief himself evaluates the paper.
- Author will take the responsibility what so ever if any copyright infringement or any other violation of any law is done by publishing the research work by the author
- Before publishing, author must check whether this journal is accepted by his employer, or any authority he intends to submit his research work. we will not be responsible in this matter.
- If at any time, due to any legal reason, if the journal stops accepting manuscripts or could not publish already accepted manuscripts, we will have the right to cancel all or any one of the manuscripts without any compensation or returning back any kind of processing cost.
- The cost covered in the publication fees is only for online publication of a single manuscript.